Neurogene expands gene therapy clinical trial for Rett syndrome treatment 05-Mar-2024 By Isabel Cameron Neurogene, a clinical-stage company developing genetic medicines, is expanding its ongoing phase 1/2 clinical trial investigating NGN-401 as a treatment for female pediatric patients with Rett Syndrome.